Phase 2 Bronchiolitis Obliterans Syndrome Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Bronchiolitis Obliterans Syndrome
Steven Hays, MD30 enrolled1 locationNCT06018766
Recruiting
Phase 2
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Lung DiseasesBronchiolitis Obliterans SyndromeChronic Graft Versus Host Disease+1 more
Dana-Farber Cancer Institute45 enrolled5 locationsNCT05922761
Recruiting
Phase 2
Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation
Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)
University Hospital, Basel, Switzerland20 enrolled3 locationsNCT03805477